Obstructive Sleep Apnea (OSA) Clinical Trial
— ICANOfficial title:
ICAN (Improvement in CPAP Adherence Via the Net) Study
Verified date | March 2013 |
Source | Mayo Clinic |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
Does an internet based text or email interaction and education improve CPAP compliance for patients with Obstructive sleep apnea (OSA) and reduce nursing intervention.
Status | Completed |
Enrollment | 50 |
Est. completion date | November 2012 |
Est. primary completion date | November 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 90 Years |
Eligibility |
Inclusion Criteria: - Adults (age 18 - 90 years of age) newly diagnosed with OSA who have been recommended CPAP therapy. Exclusion Criteria: - Previously attempted CPAP, requires the use of bilevel positive airway pressure device, difficulty with English language such that they have difficulty understanding instructions given at high school equivalent, periodic limb movement associated arousals greater than 20/hour, primary complaint of insomnia, diagnosis of restless leg syndrome or periodic limb movement disorder |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Mayo Clinic in Rochester | Rochester | Minnesota |
Lead Sponsor | Collaborator |
---|---|
Mayo Clinic |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | change in mean number of nursing interventions at one month | baseline to one month after initiation | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04939168 -
Measuring Atomoxetine and Aroxybutynin In Patients With OSA
|
Phase 2 | |
Completed |
NCT02908529 -
Atomoxetine and Oxybutynin in Obstructive Sleep Apnea
|
Phase 1/Phase 2 | |
Completed |
NCT03415633 -
Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT03426631 -
DAW1033B2 in Obstructive Sleep Apnea
|
Phase 1/Phase 2 | |
Completed |
NCT04206449 -
Sleep Thermography for Diagnosis of Obstructive Sleep Apnea (TERMOAPNEA)
|
N/A | |
Active, not recruiting |
NCT03018912 -
Validating the Use of a Subjectively Reported Sleep Vital Sign
|
N/A | |
Completed |
NCT02549508 -
Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD
|
N/A | |
Completed |
NCT01249924 -
The Effectiveness of Perioperative CPAP to Reduce Obstructive Sleep Apnea Related Adverse Events
|
N/A | |
Completed |
NCT00773721 -
Foam Mask - Assessment of Bioburden in a New Mask Seal Material
|
N/A | |
Completed |
NCT02314858 -
Tailored Treatment to Enhance Risk Perception in Sleep Apnea
|
N/A | |
Completed |
NCT01476917 -
The ATLAST Long-Term Study
|
Phase 2/Phase 3 | |
Terminated |
NCT00730041 -
Palatal Implants in Combination With Continuous Positive Airway Pressure to Treat Obstructive Sleep Apnea
|
Phase 4 | |
Completed |
NCT00850434 -
Improved Automatic CPAP Algorithm to Treat Obstructive Sleep Apnea (OSA)
|
N/A | |
Enrolling by invitation |
NCT04538755 -
DAW2020 on OSA Endotypic Traits
|
Phase 1/Phase 2 | |
Completed |
NCT02501304 -
Feasibility Study of the ReVENT Sleep Apnea System
|
N/A | |
Withdrawn |
NCT02805777 -
Vent Flow Study of Prototype Nasal CPAP Mask
|
N/A | |
Completed |
NCT02097212 -
Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea
|
N/A | |
Active, not recruiting |
NCT02295306 -
Overnight Polysomnography and Respiratory Volume Monitor
|
||
Terminated |
NCT01877928 -
Post-extubation Boussignac CPAP System in Adults With Moderate to Severe Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT01939938 -
Pilot Study of the Comparison of the Upper Airway Dynamics of Oronasal vs Nasal Masks With PAP Treatment
|
N/A |